Use of cryopreserved lymphocytes for assessment of the immunological effects of interferon therapy in renal cell carcinoma patients (Q73304007)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Use of cryopreserved lymphocytes for assessment of the immunological effects of interferon therapy in renal cell carcinoma patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

V Sobota

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Bubeník

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Indrová

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

V Vlk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Jakoubková

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

Journal of Immunological Methods

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Lymphocyte surface markers and cytotoxicity following cryopreservation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Number of interleukin-4- and interferon-γ-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Natural human interferon-alpha augments interleukin-2 production by a direct action on the activated IL-2-producing T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-gamma production of lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Induction of lymphokine-activated killer and natural killer cell activities from cryopreserved lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

The Influence of Cryopreservation on Activity and Surface Markers of Lymphokine-Activated Killer Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Properties and usefulness of the original K-562 human myelogenous leukemia cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Serum acute phase reactants and prognosis in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Lymphokine-activated killer cell activity after cryopreservation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

The prognostic significance of immune changes in patients with renal cancer and melanoma treated with interferon-alpha 2b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

High-dose combination alkylating agents with autologous bone-marrow support in patients with breast cancer: preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Extracorporeal photopheresis and recombinant interferon alfa 2b in Sezary syndrome. Use of dual marker labeling to monitor therapeutic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Functional analysis of interleukin-2 in immune surveillance against brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900020-3

10.1016/S0022-1759(97)00020-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134025%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference